Bibliografia Guillemin, R. and Burgus, R., 1972. The hormones of the hypothalamus. Sci Am. 227, 24-33. Gutierrez-Ospina, G., Calikoglu, A. S., Ye, P. and D'Ercole, A. J., 1996. In vivo effects of insulin-like growth factor-I on the development of sensory pathways: analysis of the primary somatic sensory cortex (S1) of transgenic mice. Endocrinology. 137, 5484-5492. Hachamovitch, R., Wicker, P., Capasso, J. M. and Anversa, P., 1989. Alterations of coronary blood flow and reserve with aging in Fischer 344 rats. Am J Physiol. 256, H66-73. Haley, K. J., Sunday, M. E., Osathanondh, R., Du, J., Vathanaprida, C., Karpitsky, V. V., Krause, J. E. and Lilly, C. M., 2001. Developmental expression of neurokinin A and functional neurokinin-2 receptors in lung. Am J Physiol Lung Cell Mol Physiol. 280, L1348-1358. Han, V. K., Lund, P. K., Lee, D. C. and D'Ercole, A. J., 1988. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution. J Clin Endocrinol M<strong>eta</strong>b. 66, 422-429. Harris, R. C. and Cheng, H. F., 1996. The intrarenal renin-angiotensin system: a paracrine system for the local control of renal function separate from the systemic axis. Exp Nephrol. 4 Suppl 1, 2-7. Hauser, K. F., McLaughlin, P. J. and Zagon, I. S., 1989. Endogenous opioid systems and the regulation of dendritic growth and spine formation. J Comp Neurol. 281, 13-22. Hawkins, E. F., Wade, R. and Engel, W. K., 1987. Lack of usefulness of DN-1417 for characterization of a CNS receptor for thyrotropin-releasing hormone. J Neurochem. 49, 239-245. Hawkins, R. L. and Seeds, N. W., 1989. Protease inhibitors influence the direction of neurite outgrowth. Brain Res Dev Brain Res. 45, 203-209. Hayashi, T. and Goto, S., 1998. Age-related changes in the 20S and 26S proteasome activities in the liver of male F344 rats. Mech Ageing Dev. 102, 55-66. He, W. and Barrow, C. J., 1999. The A b<strong>eta</strong> 3-pyroglutamyl and 11-pyroglutamyl peptides found in senile plaque have greater b<strong>eta</strong>-sheet forming and aggregation propensities in vitro than full-length A b<strong>eta</strong>. Biochemistry. 38, 10871-10877. Heffner, T. G., Hartman, J. A. and Seiden, L. S., 1980. A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav. 13, 453-456. Heuer, H., Schafer, M. K. and Bauer, K., 1999. Thyrotropin-releasing hormone (TRH), a signal peptide of the central nervous system. Acta Med Austriaca. 26, 119- 122. Heuer, H., Schafer, M. K., O'Donnell, D., Walker, P. and Bauer, K., 2000. Expression of thyrotropin-releasing hormone receptor 2 (TRH-R2) in the central nervous system of rats. J Comp Neurol. 428, 319-336. Heymes, C., Swynghedauw, B. and Chevalier, B., 1994. Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation. 90, 1328-1333. Higaki, J., Aoki, M., Morishita, R., Kida, I., Taniyama, Y., Tomita, N., Yamamoto, K., Moriguchi, A., Kaneda, Y. and Ogihara, T., 2000. In vivo evidence of the Bibliografia 229
Bibliografia importance of cardiac angiotensin-converting enzyme in the pathogenesis of cardiac hypertrophy. Arterioscler Thromb Vasc Biol. 20, 428-434. Hilgers, K. F., Norwood, V. F. and Gomez, R. A., 1997. Angiotensin's role in renal development. Semin Nephrol. 17, 492-501. Hirose, Y., Ogawa, N. and Mori, A., 1985. Properties of histidyl-proline diketopiperazine [cyclo(His-Pro)] binding sites in rat liver. Regul Pept. 12, 279-288. Hokfelt, T., Fuxe, K., Johansson, O., Jeffcoate, S. and White, N., 1975. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol. 34, 389-392. Hokfelt, T., Tsuruo, Y., Ulfhake, B., Cullheim, S., Arvidsson, U., Foster, G. A., Schultzberg, M., Schalling, M., Arborelius, L., Freedman, J. and et al., 1989. Distribution of TRH-like immunoreactivity with special reference to coexistence with other neuroactive compounds. Ann N Y Acad Sci. 553, 76- 105. Horita, A., 1998. An update on the CNS actions of TRH and its analogs. Life Sci. 62, 1443-1448. Horita, A., Carino, M. A. and Lai, H., 1986. Pharmacology of thyrotropin-releasing hormone. Ann Rev Pharmacol Toxicol, 311-332. Hropot, M., Langer, K. H., Wiemer, G., Grotsch, H. and Linz, W., 2003. Angiotensin II subtype AT1 receptor blockade prevents hypertension and renal insufficiency induced by chronic NO-synthase inhibition in rats. Naunyn Schmiedebergs Arch Pharmacol. 367, 312-317. Hsueh, W. A., Law, R. E. and Do, Y. S., 1998. Integrins, adhesion, and cardiac remodeling. Hypertension. 31, 176-180. Hundertmark, S., Ragosch, V., Zimmermann, B., Halis, G., Arabin, B. and Weitzel, H. K., 1999. Effect of dexamethasone, triiodothyronine and dimethyl-isopropylthyronine on lung maturation of the f<strong>eta</strong>l rat lung. J Perinat Med. 27, 309-315. Icardo, J. M., 1996. Developmental biology of the vertebrate heart. J Exp Zool. 275, 144-161. Icardo, J. M., Colvee, E., Cerra, M. C. and Tota, B., 1999. Bulbus arteriosus of the Antarctic teleosts. II. The red-blooded Trematomus bernacchii. Anat Rec. 256, 116-126. Ichai, C., Chevallier, N., Delaere, P., Dournaud, P., Epelbaum, J., Hauw, J. J., Vincent, J. P. and Checler, F., 1994. Influence of region-specific alterations of neuropeptidase content on the catabolic fates of neuropeptides in Alzheimer's disease. J Neurochem. 62, 645-655. Ihara, M., Urata, H., Shirai, K., Ideishi, M., Hoshino, F., Suzumiya, J., Kikuchi, M. and Arakawa, K., 2000. High cardiac angiotensin-II-forming activity in infarcted and non-infarcted human myocardium. Cardiology. 94, 247-253. Imai, K. and Kato, T., 1984. Dipeptidyl aminopeptidase in neonatal rat brain regions. Experientia. 40, 263-264. Irazusta, J., Larrinaga, G., Gonzalez-Maeso, J., Gil, J., Meana, J. J. and Casis, L., 2002. Distribution of prolyl endopeptidase activities in rat and human brain. Neurochem Int. 40, 337-345. Irazusta, J., Silveira, P. F., Gil, J., Varona, A. and Casis, L., 2001. Effects of hydrosaline treatments on prolyl endopeptidase activity in rat tissues. Regul Pept. 101, 141-147. 230 Bibliografia
- Page 1 and 2:
Jakintza-arloa: Medikuntza Prolil e
- Page 3 and 4:
UNIVERSIDAD DEL PAIS VASCO Eman ta
- Page 5 and 6:
Doktore-tesia Naiara Agirregoitia M
- Page 7 and 8:
Esker onak Lan hau hasi nuenetik mo
- Page 9:
David Artola Blancoren Oroimenez Es
- Page 12 and 13:
Aurkibidea SARRERA 1.NEUROPEPTIDOAK
- Page 14 and 15:
Aurkibidea 7.4. BIRIKAK 65 7.5. GIL
- Page 16:
Aurkibidea 2.4.PIROGLUTAMIL PEPTIDA
- Page 19 and 20:
Sarrera 2 Sarrera
- Page 21 and 22:
Neuropeptidoak dira: 4 Hurrengo tau
- Page 23 and 24:
Neuropeptidoak 6 1.2.4. Askapena Ne
- Page 26 and 27:
Tirotropinaren Hormona Askatzailea
- Page 28 and 29:
Tirotropinaren Hormona Askatzailea
- Page 30 and 31:
Tirotropinaren Hormona Askatzailea
- Page 32 and 33:
Tirotropinaren Hormona Askatzailea
- Page 34:
Tirotropinaren Hormona Askatzailea
- Page 37 and 38:
Prolil endopeptidasa burututako leh
- Page 39 and 40:
Prolil endopeptidasa 22 3.3. PROLIL
- Page 41 and 42:
Prolil endopeptidasa 24 3.5. GARRAN
- Page 43 and 44:
Piroglutamil peptidasa I Mutagenesi
- Page 45 and 46:
Piroglutamil peptidasa I Katuaren g
- Page 48 and 49:
5. GARUN GARAPENA 5.1. SARRERA 5.1.
- Page 50 and 51:
Garun garapena Rhombentzefaloaren k
- Page 52 and 53:
Garun garapena mekanismoa hurrengoe
- Page 54 and 55:
Garun garapena Oinarrizko morfologi
- Page 56 and 57:
Garun garapena egunetan, baina 40.
- Page 58 and 59:
Garun garapena badaude, eta entzima
- Page 60 and 61:
Garun garapena neuronen genesia (Fr
- Page 62 and 63:
Garun garapena hipotiroideoaren adi
- Page 64 and 65:
Garun garapena azpiko zati bat. Bi
- Page 66 and 67:
Garun garapena lank., 1984; Gayo et
- Page 68 and 69:
Organo periferikoen garapena 6.ORGA
- Page 70 and 71:
Organo periferikoen garapena Peptid
- Page 72 and 73:
Organo periferikoen garapena eta la
- Page 74 and 75:
Organo periferikoen garapena Birike
- Page 76:
Organo periferikoen garapena ondore
- Page 79 and 80:
Zahartzapena Entzefalinak eta TRH-a
- Page 81 and 82:
Zahartzapena Bradikininaren hartzai
- Page 83 and 84:
Zahartzapena igoerarekin bat dator.
- Page 86 and 87:
HELBURUA
- Page 88 and 89:
HELBURUA Helburua Organismoaren haz
- Page 90 and 91:
Helburua Peptidasa solugarrien egin
- Page 92 and 93:
MATERIALAK ETA METODOAK
- Page 94 and 95:
MATERIALAK ETA METODOAK Materialak
- Page 96 and 97:
3. PRODUKTU KIMIKOAK o Azetato sodi
- Page 98 and 99:
Materialak 4.2.ENTSEIU ENTZIMATIKOE
- Page 100 and 101:
B. METODOAK 1. ANIMALIEN PERFUSIO E
- Page 102 and 103:
1. IRUDIA: Animaliaren perfusioa. M
- Page 104 and 105:
3. IRUDIA: Garunaren lehenengo ebak
- Page 106 and 107:
2. LAGINEN PRESTAKUNTZA Metodoak Au
- Page 108 and 109:
Metodoak 3.AKTIBITATE ENTZIMATIKOAR
- Page 110 and 111:
Teknika Metodoak Substratu soluzioa
- Page 112 and 113:
Metodoak Materialak eta Metodoak 95
- Page 114 and 115:
EMAITZAK Prolil endopeptidasa solug
- Page 116:
UP/mg proteina 3000 2000 1000 0 Pro
- Page 119 and 120:
Mintzari loturiko prolil endopeptid
- Page 122 and 123:
1.2. PIROGLUTAMIL PEPTIDASA I 1.2.1
- Page 124:
UP/mg proteina 5000 4000 3000 2000
- Page 127 and 128:
Mintzari loturiko piroglutamil pept
- Page 129 and 130:
Prolil endopeptidasa garapenean 112
- Page 131 and 132:
Prolil endopeptidasa garapenean ham
- Page 133 and 134:
Prolil endopeptidasa garapenean PRO
- Page 135 and 136:
Prolil endopeptidasa garapenean Kor
- Page 137 and 138:
Prolil endopeptidasa solugarria gar
- Page 139 and 140:
Prolil endopeptidasa solugarria gar
- Page 141 and 142:
Prolil endopeptidasa solugarria gar
- Page 143 and 144:
Mintzari loturiko prolil endopeptid
- Page 146 and 147:
Mintzari loturiko prolil endopeptid
- Page 148 and 149:
Mintzari loturiko prolil endopeptid
- Page 150 and 151:
Mintzari loturiko prolil endopeptid
- Page 152 and 153:
UP/mg proteina 3000 2000 1000 0 Min
- Page 154 and 155:
UP/mg proteina 500 400 300 200 100
- Page 156 and 157:
UP/mg proteina 300 200 100 0 Mintza
- Page 158 and 159:
Piroglutamil peptidasa I solugarria
- Page 160 and 161:
Piroglutamil peptidasa I solugarria
- Page 162 and 163:
Piroglutamil peptidasa I solugarria
- Page 164 and 165:
Piroglutamil peptidasa I solugarria
- Page 166 and 167:
Piroglutamil peptidasa I solugarria
- Page 168 and 169:
Piroglutamil peptidasa I solugarria
- Page 170 and 171:
Mintzari loturiko piroglutamil pept
- Page 172 and 173:
Mintzari loturiko piroglutamil pept
- Page 174 and 175:
UP/mg proteina 600 400 200 0 Mintza
- Page 176 and 177:
UP/mg proteina 400 300 200 100 0 Mi
- Page 178 and 179:
UP/mg proteina 400 300 200 100 0 Mi
- Page 180 and 181:
UP/mg proteina 200 150 100 50 0 Min
- Page 182 and 183:
UP/mg proteina 150 100 50 0 Mintzar
- Page 184 and 185:
Prolil endopeptidasa zahartzapenean
- Page 186 and 187:
Prolil endopeptidasa zahartzapenean
- Page 188 and 189:
Prolil endopeptidasa zahartzapenean
- Page 190 and 191:
Prolil endopeptidasa zahartzapenean
- Page 192 and 193: Prolil endopeptidasa zahartzapenean
- Page 194 and 195: Piroglutamil peptidasa I solugarria
- Page 196 and 197: UP/ mg proteina 400 300 200 100 0 P
- Page 198: UP/ mg proteina 5000 4000 3000 2000
- Page 201 and 202: Piroglutamil peptidasa I solugarria
- Page 203 and 204: Piroglutamil peptidasa I solugarria
- Page 205 and 206: EZTABAIDA
- Page 207 and 208: EZTABAIDA 1. PROLIL ENDOPEPTIDASA P
- Page 209 and 210: Prolil endopeptidasa Jaio berrian e
- Page 211 and 212: Prolil endopeptidasa peptido hauek
- Page 213: Prolil endopeptidasa 1.4. PROLIL EN
- Page 216 and 217: Piroglutamil peptidasa I Lehen aipa
- Page 218 and 219: Piroglutamil peptidasa I TRH-aren e
- Page 221 and 222: Emaitzen Analisi orokorra 3. EMAITZ
- Page 223 and 224: ONDORIOAK
- Page 225 and 226: ONDORIOAK Ondorioak 1. Prolil endop
- Page 228: BIBLIOGRAFIA
- Page 231 and 232: Bibliografia Aoyagi, T., Hatsu, M.,
- Page 233 and 234: Bibliografia Berl, S. and Clarke, D
- Page 235 and 236: Bibliografia Carr, F. E., Need, L.
- Page 237 and 238: Bibliografia de Gandarias, J. M., C
- Page 239 and 240: Bibliografia el-Dahr, S. S., 1997.
- Page 241: Bibliografia Gil, J., 1997. Ontogen
- Page 245 and 246: Bibliografia converting enzyme inhi
- Page 247 and 248: Bibliografia Lee, H. J., Sagawa, K.
- Page 249 and 250: Bibliografia Manaker, S., Eichen, A
- Page 251 and 252: Bibliografia hormone (TRH) in the p
- Page 253 and 254: Bibliografia Otto, C., Zuschratter,
- Page 255 and 256: Bibliografia Re, R. N., 2003a. Impl
- Page 257 and 258: Bibliografia Sidman, R. L., 1961. H
- Page 259 and 260: Bibliografia ten Have-Opbroek, A. A
- Page 261 and 262: Bibliografia Weil-Malherbe, H., 197
- Page 263: Bibliografia Zagon, I. S., Verderam